Himadri Speciality Chemical Ltd has achieved a significant milestone with the commencement of operations at its first anode material production facility. The company announced this development through an official regulatory filing under Regulation 30 of the SEBI LODR Regulations, marking a major step forward in its battery materials manufacturing capabilities.

Facility Details and Capacity

The new production facility is located at Mahistikry, Hooghly, West Bengal, and has commenced operations with an initial installed capacity of 200 MTPA. This facility represents the culmination of over 10 years of dedicated in-house research and development efforts.

Technology and Value Chain Integration

The facility showcases the company's comprehensive approach to anode technology, covering the entire value chain from raw material processing to finished anode material production. This integrated approach strengthens Himadri's differentiated capabilities in advanced battery materials and positions the company strategically in the growing battery materials sector.

The production process has been specifically designed to accommodate alternative raw material feeds, ensuring both scalability and long-term resilience as market conditions evolve. This flexibility is expected to provide operational advantages as the industry continues to develop.

Strategic Context and Market Positioning

This facility launch is part of Himadri's broader strategic initiative for Lithium-ion battery component production, which was previously communicated on 06 December 2023. The overall plan involves production in phases with a total annual production capacity target of 200,000 MT.

The facility positions Himadri to address the accelerating global demand arising from two key growth sectors:

• Electric vehicles (EVs)
• Energy storage systems

Regulatory Compliance and Corporate Information

The announcement was made through proper regulatory channels, with the information being simultaneously disclosed to both BSE Limited (Listing Code: 500184) and National Stock Exchange of India Ltd (Listing Code: HSCL). The filing was signed by Company Secretary & Compliance Officer Monika Saraswat, ensuring full compliance with disclosure requirements.

Expected Impact on Business Performance

The company expects this capacity addition to further strengthen its portfolio and contribute to both production capabilities and revenue growth going forward. The facility represents a significant expansion of Himadri's manufacturing footprint in the advanced materials sector and demonstrates the company's commitment to participating in the growing battery materials market.

Himadri Speciality Chemical Ltd has submitted the final monitoring agency report from ICRA Limited for the quarter ended March 31, 2026, confirming compliance with the utilization of proceeds from its preferential issue of warrants. The report, submitted pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicates no deviation from the objects of the issue.

Issue Details

The preferential issue comprised 1,08,17,000 warrants priced at INR 316 each, aggregating to INR 341.8172 crore. The proceeds were earmarked for capital expenditure (INR 256.8172 crore) and general corporate purposes (INR 85.0000 crore). The monitoring agency confirmed that all utilization aligns with the disclosures made in the offer document.

Utilization Status

As of March 31, 2026, the company has utilized INR 229.4368 crore of the total proceeds. The utilization during Q4 FY26 amounted to INR 78.0337 crore, with capital expenditure accounting for the entire quarterly utilization. The general corporate purposes allocation remained unchanged during the quarter.

Deployment of Unutilized Proceeds

The unutilized proceeds of INR 112.3804 crore have been deployed in mutual funds and cash credit accounts. The majority of the unutilized amount (INR 111.7257 crore) is invested in various mutual fund schemes, while INR 0.6547 crore is maintained in a cash credit account. The investments include schemes from Mirae Asset, DSP, Kotak, Mahindra Manulife, Nippon Crisil-IBX, and Aditya Birla Sun Life.

Implementation Status

The monitoring agency confirmed that both capital expenditure and general corporate purpose objects are on schedule, with no delays reported. The proceeds are required to be utilized within 12 months from the receipt of the respective amount, and the company remains compliant with this requirement. No favorable or unfavorable events affecting the viability of the objects were reported during the quarter.